ArticleCureus2023
Anti-inflammatory and Antioxidant Activity of Ocimum tenuiflorum- and Stevia rebaudiana-Mediated Silver Nanoparticles: An In Vitro Study.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Gold and silver nanoparticles for safe and effective biomedical applications.Discover nano · 2026Review
- Green and Sustainable Synthesis of Silver and Gold Nanoparticles: A Stevia Leaf Extract Approach.Food science & nutrition · 2025Article
- Article
- A Study on the Antibacterial, Antispasmodic, Antipyretic, and Anti-Inflammatory Activity of ZnO Nanoparticles Using Leaf Extract fromMolecules (Basel, Switzerland) · 2024Article
- Phenolic content discrimination in Thai holy basil using hyperspectral data analysis and machine learning techniques.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNanotechnology, a field bridging material science and biology, explores various applications. Silver nanoparticles, ranging from 1 nm to 100 nm, are commonly labeled as "silver," although some contain a substantial quantity of silver oxide owing to the heightened ratio of silver atoms on the surface compared to the bulk. This characteristic establishes silver as a prominent nanoparticulate material.
methodsThe methods employed involved evaluating the anti-inflammatory effects using the bovine serum albumin (BSA) assay and antioxidant effects using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, with varying concentrations (10 µL, 20 µL, 30 µL, 40 µL, and 50 µL) of the nanoparticles.
resultsThe results indicated that the anti-inflammatory properties of the nanoparticles surpassed standard values at concentrations of 10 µL, 20 µL, and 30 µL, while the antioxidant properties were also notably surpassing standard values at equivalent concentrations. The maximum inhibition percentage was noted with 10 µL (72.5%).
conclusionThe silver nanoparticles, fortified with extracts from
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.